Omid Arasteh

7PUBLICATIONS
9CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 08, 2026
Pigmentary Changes Reported with Tyrosine Kinase Inhibitors: A Narrative Review of Mechanisms and Clinical Implications.

|Feb 16, 2026
The association between anti-acid use and tyrosine kinase inhibitor-induced hepatotoxicity.

Mohammadsalman Parsapour, Hamed Ghiami, Navid Omidkhoda

|Mar 11, 2025
Evaluation of Oral Nano-Silymarin Formulation Efficacy in the Prevention of Hand-Foot Syndrome and Neuropathy Induced by XELOX or m-FOLFOX6 Regimens in Metastatic Colorectal Cancer: A Triple-Blinded, Randomized Clinical Trial.

Hedyieh Karbasforooshan, Hossein Rahimi, Omid Arasteh

|Dec 14, 2023
Comparison of bolus administration and short-term infusion versus long-term infusion of doxorubicin in terms of cardiotoxicity and efficacy.

Hamed Ghiami, Navid Omidkhoda, Mohsen Seddigh-Shamsi

|Mar 22, 2023
A critical review of methotrexate clinical interactions: role of transporters.

Fatemeh Jafari, Omid Arasteh, Hesamoddin Hosseinjani

|Jul 20, 2022
The Effect of Heparin and Its Preparations on Disseminated Intravascular Coagulation Mortality and Hospitalization: A Systematic Review.

Navid Omidkhoda, Farshad Abedi, Vahid Ghavami

Pageof 2

Frequent Collaborators

4 joint publications

Navid Omidkhoda

2 joint publications

Vahid Ghavami

1 joint publications

Farshad Abedi

1 joint publications

Sara Samadi